Eli Lilly and Company's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
Posted:
FDA has authorized bebtelovimab for emergency use for certain non-hospitalized patients with mild-to-moderate COVID-19 at high risk of progression to severe disease for whom alternative COVID-19 treatment options approved or authorized by FDA are not accessible or clinically appropriate Bebtelovimab neutralizes Omicron as demonstrated by pseudovirus and authentic virus data.
Healthy Mind offers hypnotic speeches for each environment, catering to both adult and child profiles.
Check out the interesting article written by Rachel Branson in the Wellbeing Magazine about Healthy Mind therapeutic immersive medical device in the UK.
Congratulations!
Gill Jennings & Every LLP’s Alasdair MacQuarrie and Edward Carstairs have both been listed as ‘Highly Recommended’ individuals in the WIPR UK Trade Mark Rankings 2024.
Read more here.
Attendees
Sponsors and
Exhibitors
Media
Contact us